gusacitinib

noun1

1. •
   An experimental medication belonging to the class of Syk/Janus kinase inhibitors.

   • Gusacitinib (ASN002) is an oral JAK/Syk inhibitor that showed clinical efficacy, associated with decreased expression of inflammatory biomarkers, in a phase II trial in atopic dermatitis (77). — 2021